Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now
Quote Panel
Key Metrics
Fundamentals
Relative Strength
128940.KS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Forecast
Analyst rating
Last analyst upgrade/downgrade
Earnings Growth
YoY
Current
Estimates
Q1.23
+121%
3.5K
vs 1.6K
Q2.23
-24%
1.1K
vs 1.5K
Q3.23
+116%
4.4K
vs 2K
Q4.23
+77%
2.8K
vs 1.6K
Q1.24
+25%
4.3K
vs 3.5K
Q2.24
+183%
3.2K
vs 1.1K
Q3.24
-44%
2.4K
vs 4.4K
Q4.24
N/A
-390.73
vs 2.8K
Q1.25
-23%
3.4K
vs 4.3K
Q2.25
-99%
35.7
vs 3.2K
Sales Growth
YoY
Current
Estimates
Q2.23
+8%
342.7B vs 317.1B
Q3.23
+7%
364.6B vs 342.1B
Q4.23
+20%
422.4B vs 351.2B
Q1.24
+12%
403.7B vs 361.2B
Q2.24
+10%
378.1B vs 342.7B
Q3.24
-1%
362.1B vs 364.6B
Q4.24
-17%
351.6B vs 422.4B
Q1.25
-3%
390.9B vs 403.7B
Q2.25
+5%
397.6B vs 378.1B
Q3.25
+12%
404.5B vs 362.1B
Return on Equity
QoQ
Q2.23
+2%
0.02
vs 0.05
Q3.23
+6%
0.06
vs 0.02
Q4.23
+4%
0.04
vs 0.06
Q1.24
+5%
0.05
vs 0.04
Q2.24
+4%
0.04
vs 0.05
Q3.24
+3%
0.03
vs 0.04
Q4.24
0%
-0.00
vs 0.03
Q1.25
NA
NA
vs -0.00
Institutionnal Ownership
Quote Panel
Key Metrics
Hanmi Pharm. Co., Ltd. operates as a pharmaceutical company worldwide. It develops treatments for diabetes, obesity, cancer, autoimmune, and rare diseases. The company was founded in 1973 and is based in Seoul, South Korea.
KSC
EPS improving
EPS improving
5500.00Â ( 1.96%)
Relative Strenght
Volume Buzz
-84%
Earning Acce
No
Dist 52w H.
24%Relative Strength
128940.KS
Sector
Top 5 RS in Group
Symbol | Company | RS | 5-Day Perf. |
|---|---|---|---|
Fundamentals
P/E Ratio
P/S Ratio
P/B Ratio
Debt/Equity
Net Margin
EPS
How 128940.KS compares to sector?
Forecast
344%2026-Revenue
321%2026-EPS
415%2026-EBITDA
Analyst rating
Strong Sell
Sell
Buy
Neutral
Strong Buy
Price Target
NaN(-100.00%)
Number of analyst
Last analyst upgrade/downgrade
No Data Available